Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors
NCT01165385
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Metastatic Cancer
Interventions
DRUG:
cisplatin
DRUG:
Pazopanib
Sponsor
UNICANCER